Comparing the efficacy of laser and injection in de Quervain’s tenosynovitis

Comparing the efficacy of local corticosteroid injection and high-level laser therapy in patients diagnosed with de Quervain’s tenosynovitis.

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20221228056965N1

Enrollment

Registered

2023-09-06

Start date

2023-04-21

Completion date

Unknown

Last updated

2023-10-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

de Quervain’s tenosynovitis. Radial styloid tenosynovitis [de Quervain]

Interventions

Intervention 1: "The first Intervention group": high-power laser therapy, in this group, a gallium aluminum arsenide diode laser with a wavelength of 1064 nm, an output power of 8 watts, and an averag

Eligibility

Sex/Gender

All

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: diagnosis of de Quervain’s tenosynovitis Duration of diagnosis is at least 3 months Age 18-65 years Minimum pain intensity according to VAS>3.

Exclusion criteria

Exclusion criteria: History of recent wrist surgery or trauma Vascular diseases Corticosteroid treatment currently or within the past 4 months

Design outcomes

Primary

Measure	Time frame
Changes in the intensity of pain in the wrist. Timepoint: On arrival, 4 weeks After the intervention, 12 weeks After the intervention. Method of measurement: visual analog scale.	—

Secondary

Measure	Time frame
Quality of Life. Timepoint: On arrival, 4 weeks After the intervention, 12 weeks After the intervention. Method of measurement: 12- item short form survay.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMotahareh Pourgholam

Hamedan University of Medical Sciences

M.akbarikia@yahoo.com+98 81 3264 0033

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026